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During the COVID-19 pandemic, semi-structured interviews were undertaken with 20 adults awaiting a diagnosis for their chronic
breathlessness. Three key themes were identified using thematic analysis: (1) de-prioritisation of diagnosis, (2) following UK
‘lockdown’ guidance for the general population but patients fearful they were more at risk, and (3) the impact of lockdown on
coping strategies for managing breathlessness. The existing unpredictable pathway to diagnosis for those with chronic
breathlessness has been further interrupted during the COVID-19 pandemic.
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In March 2020, the World Health Organisation (WHO) declared a
global pandemic of coronavirus disease (COVID-19) caused by
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). At
the time of study conduct, there was no available vaccine so
public health policy was reliant on reducing the transmission1. The
UK entered national lockdown on 23rd March 2020 with specific
government guidance including the closure of non-essential
services and social distancing measures. Additional advice with
support to ‘shield’ i.e., to stay at home and minimise face-to-face
contact with others, was provided for those at risk of worse
outcomes identified by coded diagnoses from healthcare records1.
High-risk groups included people with severe respiratory or heart
disease1,2.
People living with chronic breathlessness who were yet to
receive a diagnosis for their underlying condition were not
identified as clinically vulnerable so did not receive shielding
advice or support; however, breathlessness is a common
manifestation of severe heart and lung diseases3 so many may
have been classified as ‘extremely vulnerable’ if they had received
a diagnosis. Furthermore, functional impairment from breath-
lessness (assessed by the Medical Research Council dyspnoea
scale) is associated with reduced survival regardless of underlying
diagnosis and therefore may independently be an indicator for
worse outcomes with COVID-194,5.
Breathlessness is common and surveys of the general popula-
tion indicate the prevalence is around 9–11%6,7, but people often
delay seeking help until everyday activities become significantly
impaired. Adults presenting with chronic breathlessness fre-
quently experience significant delays in diagnosis and therefore
treatment8,9. The reasons are multi-factorial and include the
complex multimorbidity of breathlessness10,11, accessibility of
investigations12, and variable adherence to disease-specific
diagnostic pathways9.
We aimed to understand the experiences and impact of
lockdown for adults who had presented with breathlessness to
primary care but were yet to receive a diagnosis.
Twenty participants were interviewed between April–May 2020:
12 female, mean (range) age of 65 (45–89) years. Sixteen
participants lived in a rural setting and four in the city, five
participants lived alone. All participants were retired except for
two participants who remained working throughout the lockdown
period. The mean (range) number of comorbidities for the patients
was 4 (0–10). None of those interviewed had been advised to
shield. As highlighted in Fig. 1 two participants were interviewed
shortly after the lockdown was eased and were included as their
diagnostic process was potentially impacted. No distinct new
codes were identified.
Three key themes were identified: (1) de-prioritisation of
diagnosis by patients and healthcare system, (2) following UK
‘lockdown’ guidance for the general population but patients
fearful they were more at risk, and (3) the impact of lockdown on
coping strategies for managing breathlessness. Table 1 contains
illustrative quotes.
People with chronic breathlessness awaiting a diagnosis
described their experiences of the first UK lockdown due to the
COVID-19 pandemic. We report de-prioritisation of seeking a
diagnosis by both patients and healthcare systems. People
perceived they were at greater risk than the general population
yet were not receiving specific shielding guidance or support. A
range of coping strategies were highlighted but people identified
that attempts to keep active and contact with others were
severely limited by the lockdown situation.
Long delays to diagnosis and therefore treatment is well
documented in conditions associated with chronic breathlessness
such as chronic obstructive pulmonary disease (COPD)8, heart
failure9 and pulmonary fibrosis13. Unfortunately, our data high-
lights further delays to a diagnosis for those with breathlessness
during the COVID-19 pandemic due to both patient behaviours
and the healthcare system. Our data indicates many patients
perceived their problems as less important when balanced with
the effects of the COVID-19 pandemic, and understood why there
were interruptions in their care. There was some anxiety around
the risk of exposure by visiting a GP surgery. However, it was
unclear when or how patients would be able to resume seeking
help for their breathlessness.
Investigations for people with breathlessness commonly
include spirometry, imaging and blood tests14. Many of these
procedures were paused during the COVID-19 pandemic and the
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availability of spirometry was extremely limited due to the
classification as an aerosol-generating procedure in UK national
guidance15. Some patients also reported an initial delay in having
blood tests but these were available once practices had
appropriate measures and personal protective equipment (PPE)
in place. The further delays to diagnosis may have harmful
consequences such as causing patients to delay seeking help
again until their symptoms are more disabling or at crisis point,
halting the process altogether for some patients, and potentially
delaying the access to effective therapy. It is currently unclear how
the healthcare system will resume these services and deal with
pre-existing requests.
Patients were concerned they were at higher risk than the
general population from COVID-19 and it is likely that many
people with chronic breathlessness would be categorised in a
higher risk group for COVID-19 once a diagnosis is confirmed16.
The quotes included in Theme 2 (Table 1) indicate an element of
fear and anxiety from patients of becoming very unwell or dying if
they contracted COVID-19. For future waves of COVID-19 or local
outbreaks, people with severe functional limitation due to
breathlessness may need to be considered as high risk with
shielding guidance to incorporate people who have yet to receive
a diagnosis or seek help.
Participants in this study described how the COVID-19
pandemic and the lockdown situation had altered their usual
coping mechanisms. The concept of ‘Breathing Space’ is a
combination of how people cope and seek help for their
breathlessness, and how healthcare professionals respond to the
needs of the person17. This concept encompasses engaged and
disengaged coping styles18 including aspects such as problem-
solving, social support, problem avoidance and social isolation,
exemplified by participants in this study. Notably, the lockdown
situation appeared to limit ‘Breathing space’ for many, as the usual
ways of managing their mental and physical health such as going
out, socialising and exercise were now severely curtailed, as were
their opportunities to seek help for their breathlessness. The
interruption in the diagnostic pathway highlighted a lack of
symptom management from initial consultations. Irrespective of
the underlying disease and availability of a diagnosis, there are
evidence-based, effective, low-cost/risk non-pharmacological stra-
tegies available to help manage breathlessness11.
Our data shows people living with chronic breathlessness but
without an established diagnosis are concerned they are at higher
risk from COVID-19 and were unable to receive the same level of
support as those ‘shielding’. Their healthcare has been interrupted
by the COVID-19 pandemic causing further delays in an already
unpredictable and long pathway to diagnosis, and methods they
employ to cope with their breathlessness symptoms were
compromised by the lockdown situation.
Patients and clinicians need to proactively re-engage with the
pathway to diagnosis, treatment and management of chronic
breathlessness. Despite challenges to ensure access to healthcare
including diagnostic services, there remain opportunities to
support patients to manage their symptoms regardless of the
diagnosis.
METHODS
Semi-structured interviews were conducted with participants enrolled
within a mixed-method feasibility study in Leicestershire, England:
Breathlessness–DiagnosE Early in Primary care (Breathe-DEEP) with
eligibility criteria of adults over forty years old, breathlessness for longer
than two months, presenting for the first time and with no prior diagnoses
accounting for their symptoms. The feasibility trial recruitment started in
November 2019; patients within six months of presenting to their GP with
breathlessness and willing to participate in an interview were eligible for
this study. All participants provided written informed consent. The original
interview guide was expanded to incorporate the pandemic situation;
existing topic areas included experiences of breathlessness, related
healthcare, and the larger research study. For this report, only data
relevant to the impact of the COVID-19 lockdown experience on the
diagnostic process were included. Figure 1 shows a timeline of the
lockdown period and when these interviews were completed.
Interviews were conducted via telephone by one of two interviewers,
who were trained in qualitative research methods, and transcribed
verbatim. The transcripts were evaluated using thematic analysis19
supported by NVivo software. The analysis process included familiarisation
with data, generating initial codes, searching for themes, reviewing
themes, defining and naming themes and producing the report. Initial
coding was carried out independently by two researchers and all
interviews were reviewed by another member of the team. The research
team discussed and reviewed the emerging themes throughout the data
analysis using quotes from the transcripts to check data interpretation. For
the third emerging theme relating to coping, Tobin’s categorisation of
coping18 was used along with the concept of ‘Breathing Space’17 to
analyse the patient’s descriptors of their coping mechanisms.
Research Ethics Committee Nottingham 1 provided ethical approval for
the mixed methods Breathe DEEP trial which is the wider basis of this
qualitative work. REC Reference: 19/EM/0201.
Fig. 1 Interviews timeline. Timeline of the interviews in relation to government guidance and the lockdown period.
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Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
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2. Following UK ‘lockdown’ guidance for the general population but fearful
they are more at risk
“It feels like you’re being a bit of a bother for nothing, because I’ve not
been actually diagnosed you see. We, who haven’t been diagnosed, are
sort of out of the picture if you know what I mean, because we don’t get
the letter for being vulnerable either… So we’re stuck.”
Description: This group were not identified as vulnerable and were
following guidance for the general population. However, many describe a
clear perception of being at increased risk if they were to contract COVID-
19.
Not being included in an ‘at risk’ group caused increased anxiety and
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“So and I suppose in a separate way it’s more of a concern to me that if I
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feed myself, I do the washing and that.”
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